Cost-utility analysis of methadone maintenance treatment: A methodological approach

Substance Use and Misuse

Volumn 41, Issue 1, 2006, Pages 87-101

  Vanagas, Giedrius ^a,c   Padaiga, Zilvinas ^a,d   Bagdonas, Eugenijus ^a,b,e  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b KAUNAS UNIVERSITY OF TECHNOLOGY   (Lithuania)

^c KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

^d Kaunas University of Medicine ^*  (Lithuania)

^e Business Administration Department   (Greece)

Author keywords

Cost accounting; Cost utility analysis; Economic evaluation; Maintenance treatment; Quality of life

Indexed keywords

METHADONE; OPIATE;

ACCURACY; ARTICLE; COST UTILITY ANALYSIS; CRIMINAL JUSTICE; DISEASE ASSOCIATION; DRUG ABUSE; DRUG SCREENING; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH PROGRAM; HIGH RISK BEHAVIOR; HUMAN; INJECTION; MAINTENANCE THERAPY; MEDICAL INSTRUMENTATION; MEDICAL LITERATURE; METHODOLOGY; MORTALITY; OPIATE ADDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; SENSITIVITY ANALYSIS; SOCIAL WORK; STATISTICAL ANALYSIS; VALIDITY;

COSTS AND COST ANALYSIS; HUMANS; LITHUANIA; METHADONE; OPIOID-RELATED DISORDERS; QUALITY OF LIFE; RESEARCH;

EID: 30344485953     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080500368751     Document Type: Article

References (52)

1. Aaronson, N. K. (1989). Quality of life assessment in clinical trials: methodologic issues. Control Clin. Trials 10(4 suppl):195-208.
2. Adam, T., Koopmanschap, M. A., Evans, D. B. (2003). Cost-effectiveness analysis: can we reduce variability in costing methods? Int. J. Technol. Assess. Health Care 19:407-420.
3. Addington-Ha, U. J., Kalra, L. (2001). Who should measure quality of life? Br. Med. J. 322:1417-1420.
4. Avants S. K., Margolin, A., Sindelar, J. L., Rounsaville, B. J., Schottenfeld, R., Stine, S. (1999). Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. Am. J. Psychiatry 156(1):27-33.
5. Barnett, P. G. (1999). The cost-effectiveness of methadone maintenance as a health care intervention. Addiction 94(4):479-488.
6. Barnett, P. G., Hui, S. S. (2000). The cost-effectiveness of methadone maintenance. Mt. Sinai. J. Med. 67(5-6):365-374.
7. Bellis, D. J. (1993). Reduction of AIDS risk among 41 heroin addicted female street prostitutes: effects of free methadone maintenance. J. Addict. Dis. 12(1):7-23.
8. Caplehorn, J. R. (1994). A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int. J. Addict. 29(11):1361-1375.
9. Caplehorn, J. R., Dalton, M. S., Cluff, M. C., Petrenas, A. M. (1994). Retention in methadone maintenance and heroin addicts' risk of death. Addiction 89(2):203-209.
10. Caplehorn, J. R., Dalton, M. S., Haldar, F., Petrenas, A. M., Nisbet, J. G. (1996). Methadone maintenance and addicts' risk of fatal heroin overdose. Subst. Use Misuse 31(2):177-196.
11. Caplehorn, J. R., Ross, M. W. (1995). Methadone maintenance and the likelihood of risky needle-sharing. Int. J. Addict. 30(6):685-698.
12. Caplehorn, J. R., Saunders, J. B. (1993). Factors associated with heroin users' AIDS risk-taking behaviours. Aust. J. Public. Health. 17(1):13-17.
13. Cella, D. F., Tulsky, D. S. (1990). Measuring quality of life today: methodological aspects. Oncology 5:29-38.
14. Creese, A., Parker, D. (1994). Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva: World Health Organization.
15. Cummins, R. A. (1996). Directory of to Measure Quality of Life and Cognate Areas, 2nd ed. Melbourne: School of Psychology, Deakin University.
16. Dempster, M., Donnelly, M. (2000). Selecting a measure of health related quality of life. Soc Work Health Care 32(1):45-56.
17. Dimenas, E. S., Dahlof, C. G., Jern, S. C., Wiklund, I. K. (1990). Defining quality of life in medicine. Scand. J. Prim. Health Care (Suppl 1):7-10.
18. Drummond, M. F., O'Brien, B., Stoddart, G. L., Torrance, G. W. (1997). Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. Oxford: Oxford University Press.
19. Flynn, P. M., Kristiansen, P. L., Porto, J. V., Hubbard, R. L. (1999). Costs and benefits of treatment for cocaine addiction in DATOS. Drug. Alcohol. Depend. 57(2):167-174.
20. French, M. T., McGeary, K. A. (1997). Estimating the economic cost of substance abuse treatment. Health. Econ. 6(5):539-544.
21. French, M. T., Salome, H., Carney, M. (2002). Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington. Soc. Sci. Med. 55(12):2267-2282.
22. Gerin, P., Dazord, A., Boissel, J., Chifflet, R. (1992). Quality of life assessment in therapeutic trials: rationale for and presentation of a more appropriate instrument. Fundam. Clin. Pharmacol. 6:263-276.
23. Giacomuzzi, S. M., Riemer, Y., Kemmler, G., Ertl, M., Richter, R., Rossler, H. (2001). [Subjective wellbeing in heroin withdrawal. With methadone the patient feels better]. MMW Fortschr. Med. 143(37):53.
24. Giacomuzzi, S. M., Riemer, Y., Ertl, M., Kemmler, G., Rossler, H., Hinterhuber, H. (2003). Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment. Addiction 98(5):693-702.
25. Gold, M. R., Siegel, J. E., Russel, L. B., Weinstein, M. C. (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
26. Guyatt, G. H., Feeny, D. H., Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine 118:622-629.
27. Holder, H. D. (1998). Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse. J. Ment. Health Policy Econ. 1(1):23-29.
28. Jefferson, T., Demicheli, V., Mugford, M. (2000). Elementary Economic Evaluation in Health Care. 2nd Ed. London: BMJ Books.
29. Jenney, M., Campbell, S. (1997). Measuring quality of life. Arch. Dis. Child. 77(4):347-350.
30. Johns, B., Baltussen, R., Hutubessy, R. (2003). Programme costs in the economic evaluation of health interventions. Cost Effectiveness and Resource Allocation 1(1):1.
31. Kishner, B., Guyatt, G. (1985). A methodological framework for assessing health indices. J. Chronic Dis. 38:27-36.
32. Korr, W. S., Ford, B. C. (2003). Measuring quality of life in the mentally ill. Qual. Life Res. 12:17-23.
33. Leidy, N. K., Revicki, D. A., Geneste, B. (1999). Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 2:113-27.
34. Little, I., Mirrlees, J. A. (1974). Project Appraisal and Planning for Developing Countries. London: Heinemann Educational Books.
35. Mendlowicz, M. V., Stein, M. B. (2000). Quality of life in individuals with anxiety disorders. Amer. J. Psych. 157(5):669-682.
36. Mishan, E. J. (1982). Cost-benefit Analysis, 3rd ed. London: George Allen & Unwin Ltd.
37. Muldoon, M. F., Barger, S. D., Flory, J. D., Manuck, S. B. (1998). What are quality of life measurements measuring? Br. Med. J. 316(7130):542-545.
38. Patrick, D. L., Erickson, P. (1993). Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York: Oxford University Press.
39. Reno, R. R., Aiken, L. S. (1993). Life activities and life quality of heroin addicts in and out of methadone treatment. Int. J. Addict. 28(3):211-232.
40. Revicki, D. A., Osoba, D., Fairclough, D., Barofsky, I., Berzon, R., Leidy, N. K. (2000). Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual. Life Res. 9:887-900.
41. Richman, A. (1983). Cost/effectiveness analysis of alcoholism and drug abuse treatment programs: the relevance of recidivism and resource absorption. Eval. Program. Plann. 6(1):49-52.
42. Salyers, M. P., Bosworth. H. B., Swanson, J. W., Lamb-Pagone, J., Osher, F. C. (2000). Reliability and validity of the SF-12 health survey among people with severe mental illness. Med. Care. 38(11):1141-50.
43. Schipper, H., Clinch, J. J., Olweny, C. L. (1996). Quality of life studies: definitions and conceptual is sues. In: Spilker, B., ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven, pp. 11-24.
44. Schumacher, J. E., Mennemeyer, S. T., Milby, J. B., Wallace, D., Nolan, K. (2002). Costs and effectiveness of substance abuse treatments for homeless persons. J. Ment. Health Policy Econ. 5(1):33-42.
45. Sindelar, J. L., Jofre-Bonet, M., French, M. T., McLellan, A. T. (2004). Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug. Alcohol. Depend. 73(1):41-50.
46. Vanagas, G., Bagdonas, E., Padaiga, Z. (2004). Cost analysis in economic evaluation of methadone maintenance treatment: a methodological approach. Drug Alcohol Abuse 2004; 17(1-2):21-28.
47. Vanagas, G., Padaiga, Z., Subata, E. (2004). Economic efficiency of the methadone maintenance and factors affecting it. Medicina (Kaunas) 40(7):607-613.
48. Vanagas, G., Padaiga, Z., Subata, E. (2004). Drug addiction maintenance treatment and quality of life measurements. Medicina (Kaunas) 2004; 40(9):833-841.
49. Ventegodt, S., Merrick, J. (2003). Psychoactive drugs and quality of life. Scientific World Journal 3(8):694-706.
50. Walker, D. (2001). How to do (or not to do)... Cost and cost-effectiveness guidelines: which ones to use? Health Policy Plan 16:113-121.
51. Ware, J. E. (1984). Methodological considerations in the selection of health status assessment procedures. In: Wenger, N. MMFCEJ, ed. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Greenwich: La Jacq, 87-111.
52. Wilkin, D., Hallam, L., Doggett, M. A. (1992). Measures of Need and Outcome for Primary Health Care. Oxford: Oxford University Press.